Gainesville, FL, United States of America

Paul Okunieff

This inventor holds 15 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 8 EPO patents. Top assignees: University of Florida Research Foundation Inc., Diacarta Ltd, Entrinsic, Inc.. Active years: 2013-2026.

USPTO Granted Patents = 15 (Patent Applications = 9)

% Patents Active = 93.3

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 67(Granted Patents)

Company Filing History:

13 out of 3,046

University of Florida Research Foundation Inc.

University of Rochester

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12611391 - Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications (2026-04-28),

2. 12239633 - Materials and methods for improving gastrointestinal function (2025-03-04),

3. 11752132 - Materials and methods for improving gastrointestinal function (2023-09-12),

4. 11576884 - Amino acid compositions and uses thereof (2023-02-14),

5. 11529325 - Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications (2022-12-20),

6. 10940137 - Materials and methods for improving gastrointestinal function (2021-03-09),

7. 10758507 - Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications (2020-09-01),

8. 10502731 - Use of anoctamin as a biomarker for radiation biodosimetry (2019-12-10),

9. 10350185 - Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications (2019-07-16),

10. 10322109 - Materials and methods for improving gastrointestinal function (2019-06-18),

11. 10086007 - Materials and methods for treatment of cystic fibrosis and for induction of ion secretion (2018-10-02),

12. 9829484 - Use of anoctamin as a biomarker for radiation biodosimetry (2017-11-28),

13. 8993522 - Materials and methods for improving gastrointestinal function (2015-03-31),

14. 8871900 - Fibroblast growth factor (FGF) analogs and uses thereof (2014-10-28),

15. 8404444 - Method for predicting the level of damage to cells by measuring free circulating Alu nucleic acid (2013-03-26),

Title: Innovations by Paul Okunieff in Gastrointestinal Health

Introduction

Paul Okunieff is an accomplished inventor based in Gainesville, FL, known for his significant contributions to health innovations, particularly in gastrointestinal function. With a total of 14 patents to his name, he has developed therapeutic solutions aimed at enhancing the health of the small intestine.

Latest Patents

Among his recent innovations are patents focused on "Materials and methods for improving gastrointestinal function." This invention provides therapeutic compositions for the treatment and amelioration of injury to the small intestine mucosa. Preferred embodiments of this composition include one or more nutrients and/or electrolytes that acquire or retain considerable absorptive capacity, showcasing his commitment to advancing medical therapies.

Career Highlights

Paul Okunieff has built a robust career within both academia and industry, notably working with the University of Florida Research Foundation, Incorporated, and Diacarta Ltd. His work reflects a dedication to researching and devising methods to enhance gastrointestinal health and overall patient well-being.

Collaborations

Collaborating with professionals in his field, Okunieff has teamed up with talents like Sadasivan Vidyasagar and Lurong Zhang. These collaborations underscore the importance of teamwork in driving innovation and enhancing research capabilities within the medical technology sector.

Conclusion

Paul Okunieff's inventive contributions are instrumental in the realm of gastrointestinal health and reflect a broader trend of innovation in therapeutic applications. His work not only exemplifies technological advancement but also emphasizes the importance of collaboration in achieving scientific breakthroughs. With 14 patents, Okunieff continues to pave the way for future discoveries in healthcare.